S. A. Klyushnikov

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons

V. A. Vigont, S. A. Klyushnikov, Olga S. Lebedeva et al. · Molecular Neurodegeneration · 2016 · 151 citations · Full text

STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease

V. A. Vigont, Dmitriy A. Grekhnev, Olga S. Lebedeva et al. · Frontiers in Cell and Developmental Biology · 2021 · 39 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Signal Transduction +15

Alpha–theta border EEG abnormalities in preclinical Huntington's disease

S. A. Klyushnikov, Natalya Abramycheva, Daria Malina et al. · Journal of the Neurological Sciences · 2014 · 35 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Neurological Disorder +7

Spinocerebellar ataxia type 1 in Russia

P. A. Slominsky, Igor V. Ovchinnikov, Elena D. Markova et al. · Journal of Neurology · 1996 · 35 citations

Neurological Disorder, Neurology, Neuroscience +2